The current financial score of Cosmos Health Inc is 7.04. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 18.99M, representing a year-over-year increase of 28.76%, while its net profit experienced a year-over-year increase of 115.22%.
The current valuation score of Cosmos Health Inc is 8.38. Its current P/E ratio is -0.51, which is -91.74% below the recent high of -0.04 and -389.31% above the recent low of -2.51.
No earnings forecast score is currently available for Cosmos Health Inc. The Pharmaceuticals industry's average is 7.83. The average price target is 4.50, with a high of 4.50 and a low of 4.50.
The current price momentum score of Cosmos Health Inc is 6.83. Currently, the stock price is trading between the resistance level at 0.39 and the support level at 0.24, making it suitable for range-bound swing trading.
The current institutional shareholding score of Cosmos Health Inc is 3.00. The latest institutional shareholding proportion is 2.84%, representing a quarter-over-quarter decrease of 67.39%.
The current risk assessment score of Cosmos Health Inc is 2.02. The company's beta value is 4.17. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.